At the genomic level, p53, p21, and NPM1 are highly expressed in most tumors including thyroid cancer, whereas PAD4 levels are low, except in acute myeloid leukemia and thymoma (Figure S7). Here, NPM1 is linked to thyroid gland carcinoma.